ArticleJAMA network open2021

Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.

Sijian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.